Combating The Global Medical Challenge Caused By Gram-negative 'superbugs': From Redeveloping The Polymyxins To Discovering Novel Antibiotics
Funder
National Health and Medical Research Council
Funding Amount
$375,012.00
Summary
Bacterial �superbugs� are becoming a major global medical challenge. Polymyxins are the last-line antibiotics against Gram-negative �superbugs� but with little pharmacological information available. I am an antimicrobial pharmacologist specialised in re-developing polymyxins, and discovering novel antibiotics against these very troublesome bacteria. My research targets the _Bad Bugs, No Drugs� disaster highlighted by the Infectious Diseases Society of America and the World Health Organization.
I am a peptide and protein chemist principally engaged in the study of the structure and function relationships of insulin-like peptides and the development of their therapeutic potential.